4/A//SEC Filing
McLaughlin Gerald W. 4/A
Accession 0001104659-19-016914
CIK 0001467652other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 8:06 PM ET
Size
5.9 KB
Accession
0001104659-19-016914
Insider Transaction Report
Form 4/AAmended
McLaughlin Gerald W.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-03-01+392,688→ 392,688 totalExercise: $2.31Exp: 2029-03-01→ Common Stock (392,688 underlying)
Footnotes (1)
- [F1]This stock option will vest in four equal, annual installments beginning on March 1, 2019.
Documents
Issuer
Neos Therapeutics, Inc.
CIK 0001467652
Entity typeother
Related Parties
1- filerCIK 0001495412
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 8:06 PM ET
- Size
- 5.9 KB